CORRECTIVE EFFECT OF CYCLOOXYGENASE INHIBITOR ON FUNCTIONAL STATUS OF MONONUCLEAR CELLS EXPRESSING TollLIKE RECEPTORS
- Authors: Kovalchuk L.V1, Khoreva M.V1, Nikonova A.S1, Grechenko V.V1, Agapov M.A1, Indarokov V.A1, Leonenko I.V1, Gorsky V.A1, Gracheva L.A1
-
Affiliations:
- Russian State Medical University, Moscow, Russia
- Issue: Vol 87, No 1 (2010)
- Pages: 45-50
- Section: Articles
- Submitted: 09.06.2023
- Published: 15.02.2010
- URL: https://microbiol.crie.ru/jour/article/view/13410
- ID: 13410
Cite item
Full Text
Abstract
Keywords
About the authors
L. V Kovalchuk
Russian State Medical University, Moscow, Russia
M. V Khoreva
Russian State Medical University, Moscow, Russia
A. S Nikonova
Russian State Medical University, Moscow, Russia
V. V Grechenko
Russian State Medical University, Moscow, Russia
M. A Agapov
Russian State Medical University, Moscow, Russia
V. A Indarokov
Russian State Medical University, Moscow, Russia
I. V Leonenko
Russian State Medical University, Moscow, Russia
V. A Gorsky
Russian State Medical University, Moscow, Russia
L. A Gracheva
Russian State Medical University, Moscow, Russia
References
- Ковальчук Л.В., Хорева М.В., Варивода А.С. и др. Роль рецепторов врожденного иммунитета в развитии острого инфаркта миокарда. Журн. микробиол. 2008, 4: 64-68.
- Ковальчук Л.В., Хорева М.В., Варивода А.С. и др. Рецепторы врожденного иммунитета: подходы к количественной и функциональной оценке Toll-подобных рецепторов. Иммунология. 2008, 4: 223-227.
- Berg J.,Fellier H., Christoph T. et al. The analgesic NSAID lornoxican inhibits cyclooxygenase (COX)-1/2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro. Inflamm.Res. 1999, 48: 369-379.
- Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 2007, 81: 1-5.
- Hietaranta A., Mustonen H., Puolakkainen P. et al. Proinflammatory effects of pancreatic elastase are mediated trough TLR4 and NF-kB. Biochem. Biophys. Res. Commun. 2004, 323 (1): 192-196.
- Hong-Geller E., Chaudhary A., Lauer S. Targeting toll-like receptor signaling pathways for design of novel immuno therapeutics. Curr. Drug. Discov. Technol. 2008, 5 (1): 29-38.
- Hong-Guang Li, Zong-Guang Zhou, Yuan Li et al. Alterations of Toll-like receptor 4 expression on peripheral blood monocytes during the early stage of human acute pancreatitis. Dig. Dis. Sci. 2007, 52: 1973-1978.
- Li Y., Zou Z.G., Xia Q.J. et al. Toll-like receptor detected in exocrine pancrease and the change of expression in cerulean-induced pancreatitis. Pancreas. 2005, 30: 375-381.
- Samarasinghe R., Tailor P., Tamura T. et al. Induction of an anti-inflammatory cytokine IL-10, in dendritic cells after toll-like receptor signaling. J. Interferon Cytokine Res. 2006, 26 (12): 893-900.
- Sawa H., Ueda T., Takeyama Y. et al. Role of Toll-like receptor 4 in the pathophysiology of severe acute pancreatitis in mice. Surg. Today. 2007, 37: 867-873.
- Slogoff M.I., Ethridge R.T., Rajaraman S., Evers B.M. COX-2 inhibition results in alterations in nuclear factor (NF)-kappaB activation but not cytokine production in acute pancreatitis. J. Gastrointest. Surg. 2004, 8 (4): 511-519.
- Takeda K., Akira S. Toll-like receptors in innate immunity. Int.Immunol. 2005, 17(1): 1-14.
- Tsan Min-Fu, Gao B. Endogenous ligands of Tolllike receptors. J. Leuk. Biol. 2004, 76: 514-519.
- Yin J., Huang Z., Xia Y. et al. Lornoxicam suppresses recurrent herpetic stromal keratitis through down-regulation of nuclear factor-kB: an experimental study in mice. Mol. Vis. 2009, 15: 1252-1259.